Your browser doesn't support javascript.
loading
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
Davies, G; Martin, L A; Sacks, N; Dowsett, M.
Afiliación
  • Davies G; Academic Department of Biochemistry, Royal Marsden Hospital, London, UK. dgiles@icr.ac.uk
Ann Oncol ; 13(5): 669-78, 2002 May.
Article en En | MEDLINE | ID: mdl-12075734
Interest in chemoprevention in oncology using suppressants of prostaglandin (PG) synthesis has been stimulated by epidemiological observations that the use of aspirin and other non-steroidal inflammatory drugs (NSAIDs) is associated with reduced incidence of some cancers, including cancer of the breast. The main target of NSAID activity is the cyclooxygenase (COX) enzyme. Two isoforms of COX have been identified: COX-1, the constitutive isoform; and COX-2. the inducible form of the enzyme. COX-2 can undergo rapid induction in response to many factors such as bacterial lipopolysaccharides, growth factors, cytokines and phorbol esters. COX-2 is overexpressed in some malignancies including carcinoma of the breast. It has been suggested that such enhanced expression may lead to increased angiogenesis such that the inhibition of COX-2 might have a general anticancer effect via decreased blood vessel formation. In addition, an association between COX-2, its main product PGE2 and aromatase activity in human breast cancer suggests that such inhibitors might have an additional, specific prophylactic mechanism for this tumour. New COX-2 inhibitors are already licensed for use in the treatment of arthritis and are well tolerated. Their potential role in chemoprevention of mammary carcinogenesis in rats has already been investigated. What remains to be seen is if these findings can be extrapolated to human studies.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antiinflamatorios no Esteroideos / Inhibidores de la Ciclooxigenasa / Prostaglandina-Endoperóxido Sintasas / Quimioprevención / Isoenzimas Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2002 Tipo del documento: Article Pais de publicación: Reino Unido
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antiinflamatorios no Esteroideos / Inhibidores de la Ciclooxigenasa / Prostaglandina-Endoperóxido Sintasas / Quimioprevención / Isoenzimas Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2002 Tipo del documento: Article Pais de publicación: Reino Unido